Peroxisome proliferator-activated receptor delta activation leads to increased transintestinal cholesterol efflux.
Peroxisome proliferator-activated receptor delta (PPARdelta) is involved in regulation of energy homeostasis. Activation of PPARdelta markedly increases fecal neutral sterol secretion, the last step in reverse cholesterol transport. This phenomenon can neither be explained by increased hepatobiliary cholesterol secretion, nor by reduced cholesterol absorption. To test the hypothesis that PPARdelta activation leads to stimulation of transintestinal cholesterol efflux (TICE), we quantified it by intestine perfusions in FVB mice treated with PPARdelta agonist GW610742. To exclude the effects on cholesterol absorption, mice were also treated with cholesterol absorption inhibitor ezetimibe or ezetimibe/GW610742. GW601742 treatment had little effect on plasma lipid levels but stimulated both fecal neutral sterol excretion ( approximately 200%) and TICE ( approximately 100%). GW610742 decreased intestinal Npc1l1 expression but had no effect on Abcg5/Abcg8. Interestingly, expression of Rab9 and LIMPII, encoding proteins involved in intracellular cholesterol trafficking, was increased upon PPARdelta activation. Although treatment with ezetimibe alone had no effect on TICE, it reduced the effect of GW610742 on TICE. These data show that activation of PPARdelta stimulates fecal cholesterol excretion in mice, primarily by the two-fold increase in TICE, indicating that this pathway provides an interesting target for the development of drugs aiming at the prevention of atherosclerosis.
Vrins
Carlos L J
CL
Department of Medical Biochemistry, Academic Medical Center, Amsterdam, The Netherlands. vrins@amc.uva.nl
van der Velde
Astrid E
AE
van den Oever
Karin
K
Levels
Johannes H M
JH
Huet
Stephane
S
Oude Elferink
Ronald P J
RP
Kuipers
Folkert
F
Groen
Albert K
AK
D000818:Animals; D001692:Biological Transport / Q000187:drug effects*; D002784:Cholesterol / Q000378:metabolism*; D004435:Eating / Q000187:drug effects; D007413:Intestinal Mucosa / Q000378:metabolism*; D007422:Intestines / Q000187:drug effects; D008074:Lipoproteins / Q000378:metabolism; D008099:Liver / Q000378:metabolism; D008297:Male; D051379:Mice; D047494:PPAR delta / Q000235:genetics / Q000378:metabolism*; D012333:RNA, Messenger; D013844:Thiazoles / Q000494:pharmacology
C503394:GW 610742; D008074:Lipoproteins; D047494:PPAR delta; D012333:RNA, Messenger; D013844:Thiazoles; D002784:Cholesterol